← Leaderboards
John Sullivan
Aeon Respire, Inc.
$2,462,600
Attributed
$2,462,600
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.2M · FY2021–23$2M$1.5M$1M$500K$0
'21
'22
'23
Funding mix
By agency
NIH$2,462,600 · 1
By mechanism
R44$2,462,600 · 1
Top collaborators
No co-investigators on record.
Others in their field
Other Emerging Leaders on “Chloride Channels”
- Zhaozhu Qiu · Johns Hopkins University$6,975,352
- Gaurav Sahay · Oregon State University$3,318,582
- John D. Lueck · University Of Rochester$2,591,222
- Richard Kevin Hite · Sloan-Kettering Inst Can Research$2,304,160
- Xue Gao · Rice University$2,031,964
- Clintoria Richards Williams · Wright State University$1,923,444
Research focus
Chloride ChannelsClinical PathologyAirway InflammationAdrenal Cortex HormonesAllergicAirway HyperresponsivenessAsthmaAutopsyAirway ObstructionAgonistBiological AvailabilityBiological MarkersAnimalsBronchial EpitheliumBronchodilationBurden Of IllnessBusinessesCalciumCalcium Channel BlockersCalcium SignalingCanis FamiliarisCapsuleChemical PropertyClinical Trials
Grant awards (3)
Inhalation Repurposing of An Approved Drug to Treat Severe Asthma$992,767
R44 · FY2023 · HL · contact PI
Inhalation Repurposing of An Approved Drug to Treat Severe Asthma$1,193,081
R44 · FY2022 · HL · contact PI
Inhalation Repurposing of An Approved Drug to Treat Severe Asthma$276,752
R44 · FY2021 · HL · contact PI